Elevate Your Market Understanding With RWD Powered Market Map Studies
Market Map or patient segmentation studies are crucial for pharma companies in understanding the size of the target patient universe, their risk stratification and in identifying the favorable patient segments. The insights thus derived are crucial to inform brand strategy as well as in further development of the patient engagement ecosystem.
Typically, these market map studies are developed using the chart audits or other similar primary research data sources. By design, these data sources have inherent challenges like sample biases, less frequent data availability and lack of reusability. Real-world data sources pose to be better alternatives, and almost all pharma companies would already be sourcing them for many other patient analytics studies. However, to navigate through the complex Real-world data, it requires robust business rules to be developed.
D Cube has the experience of helping many of our customers in migrating to Real-world data-based market map studies to enable more frequent and accurate target patient universe understanding. Our vast experience across therapeutic areas & various real-world data sources, combined with our reusable market definition code-sets help in achieving accurate market map studies. The insights derived from these market map studies are helping our customers to:
- Understand patient distributions across patient types and penetration of key brands within the same
- Deep dive into the root causes of performance to understand opportunity and improvement areas
- Regularly evaluate the performance of sales and marketing initiatives in driving the brand penetration in the targeted patient segments
Request a demo to find out how D Cube can help you to elevate your market understanding with RWD powered Market map studies in developing rigorous patient acquisition and retention strategies.